Atlas Trials

Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung

Clinical trial NCT03589547 · COMPLETED

Trial details

NCT number
NCT03589547
Sponsor
Brown University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage III Non-small-cell Lung Cancer
Start date
2019-05-13
Primary completion
2024-01-31
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.